Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.0551 USD | -0.54% | +7.83% | +48.92% |
25/04 | North American Morning Briefing : More Tech -2- | DJ |
11/04 | North American Morning Briefing : Stock Futures Edge Lower Ahead of PPI Inflation Gauge | DJ |
Business Summary
Number of employees: 18
Managers
Managers | Title | Age | Since |
---|---|---|---|
Craig Jalbert
CEO | Chief Executive Officer | 63 | - |
Martin Dekker
CTO | Chief Tech/Sci/R&D Officer | 51 | 29/15/29 |
Edwin L. Parsley
CTO | Chief Tech/Sci/R&D Officer | 63 | - |
Bobae Kim
LAW | General Counsel | 42 | 01/22/01 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Naseem Amin
CHM | Chairman | 62 | 29/15/29 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 12,232,648 | 10,394,477 ( 84.97 %) | 0 | 84.97 % |
Company contact information
Bellerophon Therapeutics, Inc.
184 Liberty Corner Road Suite 302
07059, Warren
+908 574 4770
http://www.bellerophon.comSector
1st Jan change | Capi. | |
---|---|---|
+48.92% | 674K | |
-2.63% | 102B | |
+1.62% | 96.29B | |
+2.01% | 22.18B | |
-16.67% | 21.2B | |
-9.33% | 18.31B | |
-38.74% | 17.38B | |
-13.21% | 16.36B | |
+5.41% | 13.97B | |
+33.57% | 12.17B |
- Stock Market
- Equities
- BLPH Stock
- Company Bellerophon Therapeutics, Inc.